Cargando…

A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism

OBJECTIVES: Venous thromboembolism (VTE) is a common worldwide disease. The burden of multimorbidity, that is, two or more chronic diseases, has increased. Whether multimorbidity is associated with VTE risk remains to be studied. Our aim was to determine any association between multimorbidity and VT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahrén, Jonatan, Pirouzifard, MirNabi, Holmquist, Björn, Sundquist, Jan, Halling, Anders, Sundquist, Kristina, Zöller, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277039/
https://www.ncbi.nlm.nih.gov/pubmed/37328186
http://dx.doi.org/10.1136/bmjopen-2023-072934
_version_ 1785060206433009664
author Ahrén, Jonatan
Pirouzifard, MirNabi
Holmquist, Björn
Sundquist, Jan
Halling, Anders
Sundquist, Kristina
Zöller, Bengt
author_facet Ahrén, Jonatan
Pirouzifard, MirNabi
Holmquist, Björn
Sundquist, Jan
Halling, Anders
Sundquist, Kristina
Zöller, Bengt
author_sort Ahrén, Jonatan
collection PubMed
description OBJECTIVES: Venous thromboembolism (VTE) is a common worldwide disease. The burden of multimorbidity, that is, two or more chronic diseases, has increased. Whether multimorbidity is associated with VTE risk remains to be studied. Our aim was to determine any association between multimorbidity and VTE and any possible shared familial susceptibility. DESIGN: A nationwide extended cross-sectional hypothesis - generating family study between 1997 and 2015. SETTING: The Swedish Multigeneration Register, the National Patient Register, the Total Population Register and the Swedish cause of death register were linked. PARTICIPANTS: 2 694 442 unique individuals were analysed for VTE and multimorbidity. MAIN OUTCOMES AND MEASURES: Multimorbidity was determined by a counting method using 45 non-communicable diseases. Multimorbidity was defined by the occurrence of ≥2 diseases. A multimorbidity score was constructed defined by 0, 1, 2, 3, 4 or 5 or more diseases. RESULTS: Sixteen percent (n=440 742) of the study population was multimorbid. Of the multimorbid patients, 58% were females. There was an association between multimorbidity and VTE. The adjusted odds ratio (OR) for VTE in individuals with multimorbidity (2 ≥ diagnoses) was 3.16 (95% CI: 3.06 to 3.27) compared with individuals without multimorbidity. There was an association between number of diseases and VTE. The adjusted OR was 1.94 (95% CI: 1.86 to 2.02) for one disease, 2.93 (95% CI: 2.80 to 3.08) for two diseases, 4.07 (95% CI: 3.85 to 4.31) for three diseases, 5.46 (95% CI: 5.10 to 5.85) for four diseases and 9.08 (95% CI: 8.56 to 9.64) for 5 ≥ diseases. The association between multimorbidity and VTE was stronger in males OR 3.45 (3.29 to 3.62) than in females OR 2.91 (2.77 to 3.04). There were significant but mostly weak familial associations between multimorbidity in relatives and VTE. CONCLUSIONS: Increasing multimorbidity exhibits a strong and increasing association with VTE. Familial associations suggest a weak shared familial susceptibility. The association between multimorbidity and VTE suggests that future cohort studies where multimorbidity is used to predict VTE might be worthwhile.
format Online
Article
Text
id pubmed-10277039
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102770392023-06-19 A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism Ahrén, Jonatan Pirouzifard, MirNabi Holmquist, Björn Sundquist, Jan Halling, Anders Sundquist, Kristina Zöller, Bengt BMJ Open Cardiovascular Medicine OBJECTIVES: Venous thromboembolism (VTE) is a common worldwide disease. The burden of multimorbidity, that is, two or more chronic diseases, has increased. Whether multimorbidity is associated with VTE risk remains to be studied. Our aim was to determine any association between multimorbidity and VTE and any possible shared familial susceptibility. DESIGN: A nationwide extended cross-sectional hypothesis - generating family study between 1997 and 2015. SETTING: The Swedish Multigeneration Register, the National Patient Register, the Total Population Register and the Swedish cause of death register were linked. PARTICIPANTS: 2 694 442 unique individuals were analysed for VTE and multimorbidity. MAIN OUTCOMES AND MEASURES: Multimorbidity was determined by a counting method using 45 non-communicable diseases. Multimorbidity was defined by the occurrence of ≥2 diseases. A multimorbidity score was constructed defined by 0, 1, 2, 3, 4 or 5 or more diseases. RESULTS: Sixteen percent (n=440 742) of the study population was multimorbid. Of the multimorbid patients, 58% were females. There was an association between multimorbidity and VTE. The adjusted odds ratio (OR) for VTE in individuals with multimorbidity (2 ≥ diagnoses) was 3.16 (95% CI: 3.06 to 3.27) compared with individuals without multimorbidity. There was an association between number of diseases and VTE. The adjusted OR was 1.94 (95% CI: 1.86 to 2.02) for one disease, 2.93 (95% CI: 2.80 to 3.08) for two diseases, 4.07 (95% CI: 3.85 to 4.31) for three diseases, 5.46 (95% CI: 5.10 to 5.85) for four diseases and 9.08 (95% CI: 8.56 to 9.64) for 5 ≥ diseases. The association between multimorbidity and VTE was stronger in males OR 3.45 (3.29 to 3.62) than in females OR 2.91 (2.77 to 3.04). There were significant but mostly weak familial associations between multimorbidity in relatives and VTE. CONCLUSIONS: Increasing multimorbidity exhibits a strong and increasing association with VTE. Familial associations suggest a weak shared familial susceptibility. The association between multimorbidity and VTE suggests that future cohort studies where multimorbidity is used to predict VTE might be worthwhile. BMJ Publishing Group 2023-06-16 /pmc/articles/PMC10277039/ /pubmed/37328186 http://dx.doi.org/10.1136/bmjopen-2023-072934 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Cardiovascular Medicine
Ahrén, Jonatan
Pirouzifard, MirNabi
Holmquist, Björn
Sundquist, Jan
Halling, Anders
Sundquist, Kristina
Zöller, Bengt
A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
title A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
title_full A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
title_fullStr A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
title_full_unstemmed A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
title_short A hypothesis - generating Swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
title_sort hypothesis - generating swedish extended national cross-sectional family study of multimorbidity severity and venous thromboembolism
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277039/
https://www.ncbi.nlm.nih.gov/pubmed/37328186
http://dx.doi.org/10.1136/bmjopen-2023-072934
work_keys_str_mv AT ahrenjonatan ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT pirouzifardmirnabi ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT holmquistbjorn ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT sundquistjan ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT hallinganders ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT sundquistkristina ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT zollerbengt ahypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT ahrenjonatan hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT pirouzifardmirnabi hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT holmquistbjorn hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT sundquistjan hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT hallinganders hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT sundquistkristina hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism
AT zollerbengt hypothesisgeneratingswedishextendednationalcrosssectionalfamilystudyofmultimorbidityseverityandvenousthromboembolism